The Lancet Neurology in conversation with

181 Episodes

1. Geraldine Dawson on advances in the prediction of autism during infancy

   Published: 2/16/2023
2. Ellisiv Mathiesen on tenecteplase for patients with wake-up stroke

   Published: 1/19/2023
3. Beau Ances on amyloid biomarkers in Alzheimer’s

   Published: 12/12/2022
4. Axel Petzold on the diagnosis and classification of optic neuritis

   Published: 11/16/2022
5. Maeike Zijlmans on using biomarkers to tailor epilepsy surgery

   Published: 10/18/2022
6. Jerome Siegel on sleep habits

   Published: 9/14/2022
7. Laurent Servais and Dora Markati on emerging therapies for Duchenne muscular dystrophy

   Published: 8/10/2022
8. Andreas Charidimou on new criteria for diagnosis of cerebral amyloid angiopathy

   Published: 7/13/2022
9. Sarah Tabrizi and Cristina Sampaio on classifying Huntington's and new therapies

   Published: 6/15/2022
10. Mark Hallett on functional neurological disorder

    Published: 5/13/2022
11. Eva Feldman on advances in understanding ALS

    Published: 4/13/2022
12. Estrella Morenas-Rodriguez and Christian Haass on soluble TREM2 and Alzheimer's

    Published: 4/6/2022
13. John Collinge on a treatment for CJD

    Published: 3/16/2022
14. Alexandra Durr on riluzole in patients with spinocerebellar ataxia type 2

    Published: 2/22/2022
15. Giuseppe Citerio on frailty and TBI

    Published: 1/19/2022
16. Alberto Costa on memantine in adolescents and young adults with Down syndrome

    Published: 12/20/2021
17. Olivier Rascol on amantadine for patients with movement disorders

    Published: 11/17/2021
18. Antonio Uccelli on stems cells for MS

    Published: 10/20/2021
19. Priya Palta on blood pressure control and cognitive decline

    Published: 9/15/2021
20. Adam Boxer on tau biomarkers

    Published: 8/18/2021